NO20030876D0 - Fremgangsmåte for racemisering av 1-benzyl-4-(4-fluorfenyl)-3- hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese avparoxetin - Google Patents

Fremgangsmåte for racemisering av 1-benzyl-4-(4-fluorfenyl)-3- hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese avparoxetin

Info

Publication number
NO20030876D0
NO20030876D0 NO20030876A NO20030876A NO20030876D0 NO 20030876 D0 NO20030876 D0 NO 20030876D0 NO 20030876 A NO20030876 A NO 20030876A NO 20030876 A NO20030876 A NO 20030876A NO 20030876 D0 NO20030876 D0 NO 20030876D0
Authority
NO
Norway
Prior art keywords
tetrahydropyridine
paroxetine
racemization
fluorophenyl
hydroxymethyl
Prior art date
Application number
NO20030876A
Other languages
English (en)
Other versions
NO20030876L (no
NO324944B1 (no
Inventor
Jayne Froggett
Dean Riley
Andrew Turner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20030876L publication Critical patent/NO20030876L/no
Publication of NO20030876D0 publication Critical patent/NO20030876D0/no
Publication of NO324944B1 publication Critical patent/NO324944B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20030876A 2000-08-30 2003-02-25 Fremgangsmate for racemisering av 1-benzyl-4-(4-fluorfenyl)-3-hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese av paroxetin samt slike mellomprodukter NO324944B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021147.4A GB0021147D0 (en) 2000-08-30 2000-08-30 Chemical process
PCT/EP2001/009998 WO2002018338A1 (en) 2000-08-30 2001-08-30 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine

Publications (3)

Publication Number Publication Date
NO20030876L NO20030876L (no) 2003-02-25
NO20030876D0 true NO20030876D0 (no) 2003-02-25
NO324944B1 NO324944B1 (no) 2008-01-07

Family

ID=9898420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030876A NO324944B1 (no) 2000-08-30 2003-02-25 Fremgangsmate for racemisering av 1-benzyl-4-(4-fluorfenyl)-3-hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese av paroxetin samt slike mellomprodukter

Country Status (16)

Country Link
US (1) US6949650B2 (no)
EP (1) EP1315701B1 (no)
JP (1) JP2004518620A (no)
AT (1) ATE421953T1 (no)
AU (1) AU2002213865A1 (no)
CA (1) CA2420579C (no)
CZ (1) CZ2003503A3 (no)
DE (1) DE60137577D1 (no)
ES (1) ES2320631T3 (no)
GB (1) GB0021147D0 (no)
HR (1) HRP20030227A2 (no)
HU (1) HUP0302910A3 (no)
IL (2) IL154302A0 (no)
NO (1) NO324944B1 (no)
SK (1) SK2342003A3 (no)
WO (1) WO2002018338A1 (no)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748140A (en) * 1954-10-07 1956-05-29 Rohm & Haas 3-hydroxymethyl-4-phenyltetrahydro-pyridines and their esters
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
JPH11505229A (ja) * 1995-05-17 1999-05-18 ノボ ノルディスク アクティーゼルスカブ 4−アリール−ピペリジン誘導体を製造する方法
GB9526645D0 (en) 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
HU221921B1 (hu) 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9710004D0 (en) 1997-05-17 1997-07-09 Knoll Ag Chemical process
DE19900576A1 (de) * 1999-01-09 2000-07-13 Merck Patent Gmbh Benzolderivate

Also Published As

Publication number Publication date
ES2320631T3 (es) 2009-05-27
NO20030876L (no) 2003-02-25
SK2342003A3 (en) 2003-09-11
HUP0302910A3 (en) 2008-02-28
JP2004518620A (ja) 2004-06-24
IL154302A (en) 2008-11-03
ATE421953T1 (de) 2009-02-15
NO324944B1 (no) 2008-01-07
CA2420579C (en) 2009-11-03
EP1315701B1 (en) 2009-01-28
GB0021147D0 (en) 2000-10-11
US6949650B2 (en) 2005-09-27
CZ2003503A3 (cs) 2003-08-13
US20040014786A1 (en) 2004-01-22
CA2420579A1 (en) 2002-03-07
IL154302A0 (en) 2003-09-17
HRP20030227A2 (en) 2005-02-28
EP1315701A1 (en) 2003-06-04
HUP0302910A2 (hu) 2004-01-28
AU2002213865A1 (en) 2002-03-13
DE60137577D1 (de) 2009-03-19
WO2002018338A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
GR1003796B (el) Κρυσταλλικη βαση κιταλοπραμης.
NO20040794L (no) (-)-1-(3,4-Diklorfenyl)-3-azabicyklo[3.1.0]heksan, forbindelser derav og anvendelser som en dopamin-gjenopptaks-inhibitor.
NO996108L (no) 9-oksinerytromycinderivater
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
AU4397501A (en) Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free base form
NO20053312L (no) Benzofuranderivat.
DE60120109D1 (de) Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin
SE0104250D0 (sv) Heterocyclic compounds
SE0203303D0 (sv) Novel Compounds
DK1274685T3 (da) Et pyridin-N-oxid-derivat og fremgangsmåde til omdannelse deraf til farmaceutisk effektive forbindelser
SE0203300D0 (sv) Novel Compounds
RS20050105A (en) Process for preparing 5-(4-(54) fluorophenyl)-1-(2-((2r,4r)-4- hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl)- 2-isopropyl-4- phenyl-1h-pyrrole-3- carboxylic acid phenylamide
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent
UY27587A1 (es) Heterociclos terapéuticos
BR9909260A (pt) Processo para o preparo de (r)-alfa-(2,3-dimetóxifenil)-1-[2-(4-fluoro-fenil)etil]-4-pi peridinametanol
NO20030876D0 (no) Fremgangsmåte for racemisering av 1-benzyl-4-(4-fluorfenyl)-3- hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese avparoxetin
AU2002214657A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
DK0703232T3 (da) 2,3-Dihydro-1H-isoindolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som hæmmere af serotoningenoptagelsen
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
NZ512684A (en) Salts of (R)- or (S)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide useful in treating central nervous system disorders
SE9701438D0 (sv) A new process
EE200400016A (et) Protsess 1,5-diarüül-3-trifluorometüül-delta²-pürasoliinide ratseemiliste ja enantiomeerselt puhaste derivaatide valmistamiseks
SE0203301D0 (sv) Novel Compounds
NO20016390L (no) Fremgangsmåte for fremstilling av (-)-(1S,4R) N-beskyttede 4- amino-2-cyklopenten-1-karboksylatestere

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees